Acute oral toxicity (LD50): 4500 mg/kg Mouse.
Sulfathiazole is a short-acting sulfa drug. It used to be a common oral and topical antimicrobial until less toxic alternatives were discovered. It is still occasionally used, sometimes in combination with sulfabenzamide and sulfacetamide.
Except for those formulated for vaginal use, the FDA withdrew its approval for the use of all drug products containing sulfathiazole.L43942
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Magnesium | The serum concentration of Magnesium can be decreased when it is combined with Sulfathiazole. |
| Benzylpenicillin | Sulfathiazole may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin glargine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin pork. |
| Insulin aspart | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin aspart. |
| Insulin detemir | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin detemir. |
| Insulin glulisine | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin glulisine. |
| NN344 | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with NN344. |
| Insulin beef | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin beef. |
| Insulin degludec | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin degludec. |
| Insulin argine | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin argine. |
| Insulin peglispro | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin peglispro. |
| Insulin tregopil | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin tregopil. |
| Chloroprocaine | The therapeutic efficacy of Sulfathiazole can be decreased when used in combination with Chloroprocaine. |
| Insulin icodec | The risk or severity of hypoglycemia can be increased when Sulfathiazole is combined with Insulin icodec. |